Authors:
Y. Zhao Beijing Normal University Department of Chemistry Beijing 100875 P.R. China

Search for other papers by Y. Zhao in
Current site
Google Scholar
PubMed
Close
,
C. Zhang Peking University First Hospital Department of Nuclear Medicine Beijing 100034 P.R. China

Search for other papers by C. Zhang in
Current site
Google Scholar
PubMed
Close
,
C. Qi Beijing Normal University Department of Chemistry Beijing 100875 P.R. China

Search for other papers by C. Qi in
Current site
Google Scholar
PubMed
Close
,
S. Feng Beijing Normal University Department of Chemistry Beijing 100875 P.R. China

Search for other papers by S. Feng in
Current site
Google Scholar
PubMed
Close
,
G. You Beijing Normal University Department of Chemistry Beijing 100875 P.R. China

Search for other papers by G. You in
Current site
Google Scholar
PubMed
Close
,
Z. Fu Peking University First Hospital Department of Nuclear Medicine Beijing 100034 P.R. China

Search for other papers by Z. Fu in
Current site
Google Scholar
PubMed
Close
,
F. Guo Peking University First Hospital Department of Nuclear Medicine Beijing 100034 P.R. China

Search for other papers by F. Guo in
Current site
Google Scholar
PubMed
Close
, and
R. Wang Peking University First Hospital Department of Nuclear Medicine Beijing 100034 P.R. China

Search for other papers by R. Wang in
Current site
Google Scholar
PubMed
Close
Restricted access

Abstract  

Two peptide ligands conjugated adenine, [9-N-(tritylmercapto acetyl diglycyl aminoethyl) adenine, Tr-MAG2-Ade] and [9-N-(tritylmercapto acetyl triglycyl aminoethyl) adenine, Tr-MAG3-Ade], are synthesized and labeled with 99mTc by directly labeling method. The stability of 99mTc-MAG2-adenine and 99mTc-MAG3-adenine in vitro is measured. The uptake radios of tumor to muscle at 3h post-injection are 5.70 and 4.92, respectively. The biodistribution and scintigraphic imaging studies show that the two complexes have high localization in tumor and high contrasted tumor images can be obtained, which suggest their potential utility as tumor imaging agents. But the high radioactivity of abdomen could prevent the tumor imaging in this area.

  • Collapse
  • Expand

To see the editorial board, please visit the website of Springer Nature.

Manuscript Submission: HERE

For subscription options, please visit the website of Springer Nature.

Journal of Radionalytical and Nuclear Chemistry
Language English
Size A4
Year of
Foundation
1968
Volumes
per Year
1
Issues
per Year
12
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Springer Nature Switzerland AG
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
CH-6330 Cham, Switzerland Gewerbestrasse 11.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0236-5731 (Print)
ISSN 1588-2780 (Online)